{
  "meta": {
    "title": "19_Hyperbilirubinemias_And_Tests_Of_Liver_Function",
    "url": "https://brainandscalpel.vercel.app/19-hyperbilirubinemias-and-tests-of-liver-function-d302a2b2.html",
    "scrapedAt": "2025-11-30T12:28:28.945Z"
  },
  "questions": [
    {
      "text": "A 4-month-old child was brought with a history of recurrent episodes of jaundice. Blood investigations were suggestive of hereditary spherocytosis.  Which of the following liver function test findings is likely to be seen here?",
      "choices": [
        {
          "id": 1,
          "text": "Direct bilirubin >50% of total bilirubin"
        },
        {
          "id": 2,
          "text": "Direct bilirubin >85% of total bilirubin"
        },
        {
          "id": 3,
          "text": "Direct bilirubin >15% of total bilirubin"
        },
        {
          "id": 4,
          "text": "Direct bilirubin <15% of total bilirubin"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario describes <strong>recurrent</strong>&nbsp;<strong>hemolysis </strong>in a patient with hereditary spherocytosis leading to<strong> jaundice</strong>. In hemolytic conditions, only the unconjugated/ <strong>indirect bilirubin</strong> is<strong> raised</strong> and conjugated/<strong>direct bilirubin</strong> remains&nbsp;<strong>normal</strong> i.e. &lt;15% of total bilirubin.</p>\n<p><strong>Bilirubin</strong> is synthesized from heme which is <strong>released</strong> primarily from the <strong>breakdown of old RBCs</strong>. This bilirubin is in its&nbsp;<strong>unconjugated </strong>form.<strong>&nbsp;</strong>It&nbsp;enters the circulation and reaches the<strong> liver</strong>. It&nbsp;is converted to <strong>conjugated bilirubin</strong> which is then secreted into the <strong>biliary tree</strong>.</p>\n<p>Therefore, in a healthy person,&nbsp;<strong>most </strong>of the<strong> circulating bilirubin</strong> is unconjugated/<strong>indirect bilirubin</strong>. Hence, the normal liver function tests show indirect bilirubin <strong>&gt;85%</strong> and direct/conjugated bilirubin &lt;15% of the total bilirubin. The normal bilirubin values are as follows:</p>\n<ul>\n<li>Total bilirubin levels - 1 to 1.5 mg/dL</li>\n<li>Direct bilirubin - &lt;0.3 mg/dL</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0785",
      "difficulty": "medium"
    },
    {
      "text": "A 2-week-old baby presented with yellowish discoloration of the skin. Investigations revealed markedly elevated direct bilirubin levels. Which of the following conditions should be suspected in the newborn?",
      "choices": [
        {
          "id": 1,
          "text": "Biliary atresia"
        },
        {
          "id": 2,
          "text": "Physiological jaundice"
        },
        {
          "id": 3,
          "text": "Breast milk jaundice"
        },
        {
          "id": 4,
          "text": "Hemolytic disease of the newborn"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>raised direct bilirubin levels</strong> indicate <strong>conjugated hyperbilirubinemia</strong>. Among the given options, <strong>biliary atresia</strong> causes conjugated hyperbilirubinemia.</p>\n<p><strong>Biliary atresia</strong> is a disorder characterised by&nbsp;<strong>destruction</strong> or <strong>absence </strong>of<strong> bile ducts</strong> in a newborn. It leads to obstruction to the flow of bile thereby causing leaking of conjugated bilirubin into the circulation.</p>\n<p>Option B:<strong> Physiological jaundice</strong> of the newborn occurs due to&nbsp;<strong>immaturity</strong> of the newborn's<strong>&nbsp;liver.</strong>&nbsp; It is not able to conjugate the excess bilirubin produced after birth. It leads to <strong>unconjugated</strong> hyperbilirubinemia.</p>\n<p>Option C: <strong>Breast milk</strong>&nbsp;may contain certain <strong>factors </strong>that<strong> inhibit </strong>the<strong> conjugation</strong> of bilirubin leading to <strong>unconjugated</strong> hyperbilirubinemia.</p>\n<p>Option D: <strong>Hemolytic disease of the newborn</strong> causes&nbsp;excess production of bilirubin due to<strong> hemolysis</strong> leading to&nbsp;<strong>unconjugated</strong> hyperbilirubinemia.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0801",
      "difficulty": "medium"
    },
    {
      "text": "Investigations performed in a patient with recurrent jaundice gave the following results. What is the possible cause of jaundice in this patient?<div class='question-desc-html'><p>Total bilirubin - 4 mg/dL</p>\n<p>Urine bilirubin +</p>\n<p>&nbsp;</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Hemolytic anaemia"
        },
        {
          "id": 2,
          "text": "Gilbert syndrome"
        },
        {
          "id": 3,
          "text": "Criggler-Najjar syndrome"
        },
        {
          "id": 4,
          "text": "Dubin Johnson syndrome"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The presence of <strong>urinary bilirubin</strong>&nbsp;and increased total bilirubin indicates <strong>conjugated hyperbilirubinemia</strong>. Among the given options, <strong>Dubin Johnson syndrome</strong> causes conjugated hyperbilirubinemia.</p>\n<p>Only <strong>conjugated bilirubin</strong> can appear in the urine because it is <strong>water-soluble</strong> and filterable by the kidney. <strong>Unconjugated bilirubin</strong> is water-insoluble and <strong>bound to albumin</strong>, hence it cannot be filtered by the kidney.</p>\n<p><strong>Causes</strong> <strong>of</strong> <strong>unconjugated</strong> <strong>hyperbilirubinemia</strong>:</p>\n<ul>\n<li>Increased bilirubin production-</li>\n<ul>\n<li>Hemolytic anemias&nbsp;</li>\n<li>Hematomas</li>\n</ul>\n<li>Impaired bilirubin uptake and conjugation-</li>\n<ul>\n<li>Gilbert syndrome</li>\n<li>Crigler Najjar syndrome</li>\n<li>Drugs - Probenecid, Rifampin</li>\n</ul>\n</ul>\n<p><strong>Causes</strong> <strong>of conjugated hyperbilirubinemia</strong>:</p>\n<ul>\n<li>Hereditary cholestatic syndromes</li>\n<li>Dubin Johnson syndrome</li>\n<li>Rotor syndrome</li>\n<li>Biliary obstruction</li>\n</ul><hr><h3>Related Pearl: Hereditary Hyperbilirubinemias</h3><table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Inheritance</strong></td>\n<td><strong>Defects in bilirubin metabolism</strong></td>\n<td><strong>Clinical course</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Unconjugated Hyperbilirubinemia</strong></p>\n</td>\n<td> </td>\n<td> </td>\n<td> </td>\n</tr>\n<tr>\n<td>\n<p>Crigler-Najjar syndrome type I</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Absent UGT1A1 activity</p>\n</td>\n<td>\n<p>Fatal in the neonatal period</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Crigler-Najjar syndrome type II</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Decreased UGT1A1 activity</p>\n</td>\n<td>\n<p>Generally mild,</p>\n<p>occasional kernicterus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gilbert syndrome</p>\n</td>\n<td>\n<p>AR (common)</p>\n<p>AD (occasional)</p>\n</td>\n<td>\n<p>Decreased UGT1A1 activity</p>\n</td>\n<td>\n<p>Innocuous</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Conjugated Hyperbilirubinemia</strong></p>\n</td>\n<td> </td>\n<td> </td>\n<td> </td>\n</tr>\n<tr>\n<td>\n<p>Dubin-Johnson syndrome</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Impaired biliary excretion of bilirubin glucuronides due to a mutation in canalicular multidrug resistance protein 2 (MRP2)</p>\n</td>\n<td>\n<p>Innocuous with black pigmentation of liver</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rotor syndrome</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Decreased hepatic uptake and storage</p>\n<p>Decreased biliary excretion</p>\n</td>\n<td>\n<p>Innocuous</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7407",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is a cause of unconjugated hyperbilirubinemia?",
      "choices": [
        {
          "id": 1,
          "text": "Probenecid"
        },
        {
          "id": 2,
          "text": "Amoxicillin-clavulanate"
        },
        {
          "id": 3,
          "text": "Acute hepatitis"
        },
        {
          "id": 4,
          "text": "Stone in the common bile duct"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Probenecid</strong> causes <strong>impaired hepatic uptake</strong> of bilirubin<strong>&nbsp;</strong>which leads to<strong>&nbsp;unconjugated hyperbilirubinemia.</strong></p>\n<p>Amoxicillin-clavulanate, acute hepatitis and stone in the common bile duct are causes that lead to mixed hyperbilirubinemia (both conjugated and unconjugated bilirubin elevated) or predominantly conjugated hyperbilirubinemias.</p>\n<p>Levels of conjugated and unconjugated bilirubin are useful in determining pre-hepatic causes of jaundice but are not useful in differentiating between intrahepatic and post-hepatic causes of jaundice.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7433",
      "difficulty": "medium"
    },
    {
      "text": "A 24-year-old woman presents with jaundice. She had been on OCPs for the past month. Her LFT and liver biopsy findings are given below. What is the probable diagnosis?<div class='question-desc-html'><p>Total bilirubin - 12 mg/dL</p>\n<p>Direct bilirubin - 10 mg/dL</p>\n<p>AST - 28 IU/L</p>\n<p>ALT - 30 IU/L</p>\n<p>GGT - 20 IU/L</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Gilbert syndrome"
        },
        {
          "id": 2,
          "text": "Crigler- Najjar syndrome"
        },
        {
          "id": 3,
          "text": "Rotor syndrome"
        },
        {
          "id": 4,
          "text": "Dubin Johnson syndrome"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario is suggestive of&nbsp;<strong>Dubin Johnson syndrome&nbsp;</strong>(DJS). The LFT describes <strong>conjugated hyperbilirubinemia</strong>&nbsp;with normal liver enzyme levels. The given image of microscopic examination of liver <strong>biopsy </strong>shows an accumulation of <strong>dark melanin-like pigment</strong> in the hepatocytes which is seen in this condition.</p>\n<p>DJS is an <strong>autosomal recessive</strong> condition causing <strong>defective expression </strong>of<strong> MRP 2 protein</strong>&nbsp;which is important for the biliary excretion of conjugated bilirubin. The&nbsp;patient has icterus but is otherwise asymptomatic.</p>\n<p>DJS also impairs biliary excretion of various compounds like <strong>epinephrine metabolites</strong>. The <strong>dark melanin-like pigment</strong> is derived from these metabolites causing the liver to appear black.</p>\n<p><strong>Rotor syndrome</strong> is also an autosomal recessive condition causing&nbsp;<strong>conjugated hyperbilirubinemia</strong> but it does not present with pigmentation of the liver.&nbsp;</p>\n<p><strong>Gilbert</strong> and <strong>Crigler-Najjar</strong> syndromes are characterized by <strong>unconjugated hyperbilirubinemia</strong>.</p><hr><h3>Related Pearl: Rotor syndrome vs Dubin johnson syndrome</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Rotor syndrome</strong></td>\n<td><strong>Dubin Johnson syndrome</strong></td>\n</tr>\n<tr>\n<td>Inheritance</td>\n<td>Autosomal recessive</td>\n<td>Autosomal recessive</td>\n</tr>\n<tr>\n<td>Defect</td>\n<td>Organic anion transporting polypeptide &nbsp;defect.(OATP1B1,OATP1B3)</td>\n<td>Multi drug resistance protein (MRP )2 mutation</td>\n</tr>\n<tr>\n<td>Kernicterus</td>\n<td>Absent</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td>Biopsy</td>\n<td>Normal</td>\n<td>Black pigmentation</td>\n</tr>\n<tr>\n<td>Total Urinary &nbsp;coproporphyrin</td>\n<td>Elevated</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td>Urinary &nbsp;coproporphyrin I</td>\n<td>&lt;70%</td>\n<td>&gt;80%</td>\n</tr>\n<tr>\n<td>Bromsulphalein clearance test</td>\n<td>Slow clearance</td>\n<td>No/Delayed clearance</td>\n</tr>\n<tr>\n<td>Gall bladder on oral cholangiography</td>\n<td>Visualized</td>\n<td>Not visualized</td>\n</tr>\n<tr>\n<td>Cholestasis</td>\n<td>No</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Serum bile acids</td>\n<td>Normal</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td>Jaundice</td>\n<td>Mild (TB&lt;4mg/dl)</td>\n<td>Mild (TB&lt;4mg/dl)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/c71b91e8a4c54685a18d7692c7228b17.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0802",
      "difficulty": "medium"
    },
    {
      "text": "What is the defect seen in patients with Rotor syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Absent UDP glucuronosyl transferase"
        },
        {
          "id": 2,
          "text": "Mutation in organic anion transport protein"
        },
        {
          "id": 3,
          "text": "Mutation in multidrug resistance–associated protein 2"
        },
        {
          "id": 4,
          "text": "Reduced UDP glucuronosyl transferase"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Rotor syndrome </strong>occurs due to<strong> mutation in OATP </strong>(organic anion transport protein)<strong> 1B1 </strong>and <strong>1B3.</strong></p>\n<p>Rotor syndrome is an inherited&nbsp;<strong>autosomal recessive&nbsp;</strong>disorder with <strong>conjugated hyperbilirubinemia</strong>. It is a benign disorder with mild elevation of bilirubin levels. It is similar to Dubin Johnson syndrome but the liver does not show any black pigmentation.&nbsp;<strong>No treatment</strong> is <strong>required</strong> for these patients.</p><hr><h3>Related Pearl: Hereditary Hyperbilirubinemias</h3><table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Inheritance</strong></td>\n<td><strong>Defects in bilirubin metabolism</strong></td>\n<td><strong>Clinical course</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Unconjugated Hyperbilirubinemia</strong></p>\n</td>\n<td> </td>\n<td> </td>\n<td> </td>\n</tr>\n<tr>\n<td>\n<p>Crigler-Najjar syndrome type I</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Absent UGT1A1 activity</p>\n</td>\n<td>\n<p>Fatal in the neonatal period</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Crigler-Najjar syndrome type II</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Decreased UGT1A1 activity</p>\n</td>\n<td>\n<p>Generally mild,</p>\n<p>occasional kernicterus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gilbert syndrome</p>\n</td>\n<td>\n<p>AR (common)</p>\n<p>AD (occasional)</p>\n</td>\n<td>\n<p>Decreased UGT1A1 activity</p>\n</td>\n<td>\n<p>Innocuous</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Conjugated Hyperbilirubinemia</strong></p>\n</td>\n<td> </td>\n<td> </td>\n<td> </td>\n</tr>\n<tr>\n<td>\n<p>Dubin-Johnson syndrome</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Impaired biliary excretion of bilirubin glucuronides due to a mutation in canalicular multidrug resistance protein 2 (MRP2)</p>\n</td>\n<td>\n<p>Innocuous with black pigmentation of liver</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rotor syndrome</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Decreased hepatic uptake and storage</p>\n<p>Decreased biliary excretion</p>\n</td>\n<td>\n<p>Innocuous</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7403",
      "difficulty": "easy"
    },
    {
      "text": "While evaluating a patient with jaundice, all of the following investigations would help you to differentiate between Dubin Johnson syndrome and Rotor syndrome except:",
      "choices": [
        {
          "id": 1,
          "text": "Oral cholecystography"
        },
        {
          "id": 2,
          "text": "Total urinary coproporphyrin"
        },
        {
          "id": 3,
          "text": "Serum bilirubin levels"
        },
        {
          "id": 4,
          "text": "Bromsulphalein clearance test"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Serum bilirubin levels are not helpful in differentiating between <strong>Dubin Johnson</strong> syndrome (DJS) and <strong>Rotor's</strong> syndrome as both these conditions present with <strong>mild elevation</strong> of <strong>serum bilirubin</strong>.</p>\n<p>These two conditions can be differentiated as follows:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Test</strong></td>\n<td><strong>Rotor Syndrome</strong></td>\n<td><strong>Dubin Johnson syndrome</strong></td>\n</tr>\n<tr>\n<td>Oral cholecystography</td>\n<td>Gall bladder is visualized</td>\n<td>\n<p>Gall bladder not visualised&nbsp;</p>\n<p>Impaired ability to concentrate the contrast material into bile</p>\n</td>\n</tr>\n<tr>\n<td>Total urinary coproporphyrin</td>\n<td>Elevated</td>\n<td>\n<p>Normal&nbsp;</p>\n<p>Increased excretion of coproporphyrin 1 and decreased excretion of coproporphyrin 3</p>\n</td>\n</tr>\n<tr>\n<td>Bromsulphalein (BSP) clearance test</td>\n<td>\n<p>Delayed clearance of BSP</p>\n<p>No reflux</p>\n</td>\n<td>\n<p>Rise in plasma levels of BSP after 90 minutes of injection</p>\n<p>Reflux of BSP from hepatocytes&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Rotor syndrome vs Dubin johnson syndrome</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Rotor syndrome</strong></td>\n<td><strong>Dubin Johnson syndrome</strong></td>\n</tr>\n<tr>\n<td>Inheritance</td>\n<td>Autosomal recessive</td>\n<td>Autosomal recessive</td>\n</tr>\n<tr>\n<td>Defect</td>\n<td>Organic anion transporting polypeptide &nbsp;defect.(OATP1B1,OATP1B3)</td>\n<td>Multi drug resistance protein (MRP )2 mutation</td>\n</tr>\n<tr>\n<td>Kernicterus</td>\n<td>Absent</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td>Biopsy</td>\n<td>Normal</td>\n<td>Black pigmentation</td>\n</tr>\n<tr>\n<td>Total Urinary &nbsp;coproporphyrin</td>\n<td>Elevated</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td>Urinary &nbsp;coproporphyrin I</td>\n<td>&lt;70%</td>\n<td>&gt;80%</td>\n</tr>\n<tr>\n<td>Bromsulphalein clearance test</td>\n<td>Slow clearance</td>\n<td>No/Delayed clearance</td>\n</tr>\n<tr>\n<td>Gall bladder on oral cholangiography</td>\n<td>Visualized</td>\n<td>Not visualized</td>\n</tr>\n<tr>\n<td>Cholestasis</td>\n<td>No</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Serum bile acids</td>\n<td>Normal</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td>Jaundice</td>\n<td>Mild (TB&lt;4mg/dl)</td>\n<td>Mild (TB&lt;4mg/dl)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7418",
      "difficulty": "medium"
    },
    {
      "text": "In a patient with unconjugated hyperbilirubinemia, which feature helps confirm the diagnosis of Crigler- Najjar syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Presence of kernicterus"
        },
        {
          "id": 2,
          "text": "Absence of hemolysis"
        },
        {
          "id": 3,
          "text": "UGT1A1 mutation"
        },
        {
          "id": 4,
          "text": "Autosomal recessive inheritance"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Kernicterus</strong>&nbsp;is seen in<strong> Crigler-Najjar syndrome</strong> but not in Gilbert syndrome. Gilbert syndrome does not cause a significant elevation in unconjugated bilirubin to cause kernicterus.</p>\n<p><strong>Crigler-Najjar</strong> syndrome and <strong>Gilbert</strong> syndrome are both caused by various<strong> mutations </strong>in the <strong>UGT1A1 gene</strong>. This leads to <strong>decreased activity</strong> of bilirubin <strong>UDP-glucuronosyltransferase</strong> enzyme leading to <strong>unconjugated hyperbilirubinemia</strong>. Both are predominantly inherited in an <strong>autosomal</strong> <strong>recessive</strong> pattern.&nbsp;</p>\n<p>These syndromes present with <strong>jaundice </strong>in<strong> infants</strong>. The unconjugated hyperbilirubinemia in these syndromes is not associated with any hemolysis. All the other liver function tests are usually normal.</p>\n<p><strong>Crigler Najjar</strong> syndrome may lead to kernicterus causing severe brain damage. <strong>Liver transplantation</strong> is required without which the infant may not survive beyond 1-2 years of age. Whereas,&nbsp;<strong>Gilbert</strong> syndrome is a benign <strong>asymptomatic</strong> condition that does not need any intervention.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7411",
      "difficulty": "medium"
    },
    {
      "text": "An infant presented with yellow discolouration of the skin, poor feeding, and seizures. Investigations revealed total bilirubin- 40 mg/dL and unconjugated bilirubin- 34 mg/dL. Phenobarbitone was administered while blood was being arranged for an exchange transfusion. However, there was no improvement. What is the most probable diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Gilbert syndrome"
        },
        {
          "id": 2,
          "text": "Crigler-Najjar syndrome type 1"
        },
        {
          "id": 3,
          "text": "Crigler-Najjar syndrome type 2"
        },
        {
          "id": 4,
          "text": "Rotor syndrome"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario with poor feeding and seizures is indicative of <strong>kernicterus. </strong>This accompanied with <strong>unconjugated hyperbilrubinemia</strong> is highly suggestive of <strong>Crigler-Najjar syndrome type 1</strong>.</p>\n<p><strong>No improvement</strong> in bilirubin levels<strong> following</strong> the administration of <strong>phenobarbital</strong> further supports the diagnosis. </p>\n<p><strong>Crigler-Najjar syndrome</strong> is of two types with<strong> type 1</strong> having <strong>absent/trace enzyme activity</strong> and <strong>type 2</strong> having<strong> &lt;10% of the normal enzyme activity</strong>. Hence, type 1 is far more severe and leads to kernicterus and neurological damage. Type 2 may also lead to kernicterus occasionally. </p>\n<p><strong>Kernicterus</strong> occurs because the <strong>unconjugated bilirubin</strong> is <strong>lipid-soluble</strong> and hence <strong>crosses the blood-brain barrier</strong>. </p>\n<p><strong>Phenobarbital</strong> is an <strong>enzyme inducer</strong>. Its administration can be used to differentiate between type 1 and type 2 Crigler-Najjar.</p>\n<ul>\n<li>Enzyme induction by phenobarbital leads to <strong>improved conjugation</strong> of bilirubin leading to a reduction in total bilirubin level <strong>in type 2 Crigler-Najjar</strong> syndrome.</li>\n<li><strong>No improvement</strong> is seen <strong>in type 1</strong> as the enzyme activity is absent and therefore cannot be induced.</li>\n</ul>\n<p>Inherited unconjugated hyperbilirubinemias (Autosomal Recessive) include:</p>\n<table>\n<tbody>\n<tr>\n<td> </td>\n<td>\n<p>Crigler-Najjar type  I</p>\n</td>\n<td>\n<p>Crigler-Najjar type II</p>\n</td>\n<td>Gilbert Syndrome</td>\n</tr>\n<tr>\n<td>UDP-GT Activity </td>\n<td>Absent</td>\n<td>Markedly reduced</td>\n<td>Reduced</td>\n</tr>\n<tr>\n<td>Serum bilirubin</td>\n<td>20 - 45 mg/dl</td>\n<td>&lt;20 mg/dl</td>\n<td>Generally &lt;3 mg/dl</td>\n</tr>\n<tr>\n<td>Pheno-barbital effect on serum bilirubin</td>\n<td>No effect</td>\n<td>Reduction</td>\n<td>Reduction</td>\n</tr>\n<tr>\n<td>Outcome</td>\n<td>Kernicterus</td>\n<td>Usually benign, kernicterus is rare </td>\n<td>Benign</td>\n</tr>\n<tr>\n<td>Prevalence</td>\n<td>Rare </td>\n<td>Rare</td>\n<td> Common</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note: Rotor syndrome causes conjugated hyperbilirubinemia.</p><p>The normal serum bilirubin (between 1 and 1.5 mg/dL) present in serum represents a balance between input from the production of bilirubin and hepatic/biliary removal of the pigment.</p>\n<p>Isolated elevation of the bilirubin:</p>\n<ul>\n<li>Conjugated hyperbilirubinemia- &gt;15% conjugated bilirubin</li>\n<li>Unconjugated hyperbilirubinemia- &lt;15% conjugated bilirubin</li>\n</ul>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7412",
      "difficulty": "easy"
    },
    {
      "text": "An 8-year-old child presents with jaundice and easy fatiguability. He had a history of ear infection which was treated with amoxicillin-clavulanic acid. Investigations done are shown below. What is the most likely diagnosis?<div class='question-desc-html'><p>Hemoglobin - 8 g/dL</p>\n<p>Total bilirubin level - 4.5 mg/dl</p>\n<p>Direct bilirubin - 0.8 mg/dl</p>\n<p>ALT - 45 IU/L</p>\n<p>AST - 42 IU/L</p>\n<p>Other liver function tests - normal</p>\n<p>Ultrasound shows the presence of gall stones</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Drug induced hepatitis"
        },
        {
          "id": 2,
          "text": "Hemolytic jaundice"
        },
        {
          "id": 3,
          "text": "Obstructive jaundice"
        },
        {
          "id": 4,
          "text": "Gilbert syndrome"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of <strong>hemolytic jaundice</strong>. It can present with the following features:</p>\n<ul>\n<li><strong>Low hemoglobin</strong></li>\n<li><strong>Unconjugated hyperbilirubinemia</strong></li>\n<li>Pigment <strong>gall stones</strong> - excess bilirubin in bile&nbsp;</li>\n<li>Development of cholestasis when the gall stones obstruct the flow of bile. This would result in the elevation of conjugated bilirubin and LFTs show a cholestatic picture.</li>\n</ul>\n<p>Hepatic and obstructive causes of jaundice are not likely as the other liver function tests are normal. The various causes of jaundice can be differentiated as follows:</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;<strong>Jaundice</strong></td>\n<td><strong>Pre hepatic</strong></td>\n<td><strong>Hepatic</strong></td>\n<td><strong>Post hepatic</strong></td>\n</tr>\n<tr>\n<td><strong>Cause</strong></td>\n<td>\n<p>Excessive amount of bilirubin is presented to the liver</p>\n</td>\n<td>\n<p>Impaired cellular uptake/ defective conjugation/ defective secretion of bilirubin</p>\n</td>\n<td>Defective excretion due to mechanical obstruction to the flow of bile</td>\n</tr>\n<tr>\n<td><strong>LFT</strong></td>\n<td>Elevated unconjugated bilirubin</td>\n<td>\n<p>Elevated conjugated and unconjugated bilirubin</p>\n<p>Marked elevated levels of AST and ALT (&gt;1000U/L)</p>\n</td>\n<td>\n<p>Elevated conjugated bilirubin</p>\n<p>Elevated levels of ALP and GGT</p>\n</td>\n</tr>\n<tr>\n<td><strong>Example</strong></td>\n<td>Hemolytic anaemia</td>\n<td>Hepatitis</td>\n<td>Choledocholithiasis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Inherited hyperbilirubinemias like <strong>Gilbert syndrome</strong> are suspected when there is <strong>no associated hemolysis</strong>. It is unlikely&nbsp;in this patient because there are clear hemolytic features.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7437",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following conditions is associated with increased activity of 5’- nucleotidase?",
      "choices": [
        {
          "id": 1,
          "text": "Bone diseases"
        },
        {
          "id": 2,
          "text": "Prostate cancer"
        },
        {
          "id": 3,
          "text": "Chronic renal failure"
        },
        {
          "id": 4,
          "text": "Cholestatic disorders"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>5ʹ-nucleotidase</strong> is usually <strong>elevated</strong> in <strong>cholestasis</strong>.</p>\n<p>Enzymes elevated in cholestasis are :</p>\n<ul>\n<li>Alkaline phosphatase (ALP)</li>\n<li>5ʹ-nucleotidase</li>\n<li>&gamma;-glutamyl transpeptidase (GGT)</li>\n</ul>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7431",
      "difficulty": "easy"
    },
    {
      "text": "Which among the following is the most specific indicator of liver cell injury?",
      "choices": [
        {
          "id": 1,
          "text": "Alkaline phosphatase"
        },
        {
          "id": 2,
          "text": "Gamma glutamyl transpeptidase"
        },
        {
          "id": 3,
          "text": "Alanine aminotransferase"
        },
        {
          "id": 4,
          "text": "Aspartate aminotransferase"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Among the given options,<strong> alanine aminotransferase</strong> is the <strong>most specific</strong> indicator of liver cell injury.</p>\n<p>Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are indicators of liver cell injury. This is because ALT is found primarily in the liver, whereas, AST is found in the liver, cardiac muscle, skeletal muscle, kidneys, brain, pancreas, etc.</p>\n<p class=\"p1\"><strong>GGT</strong> and <strong>ALP</strong> are enzymes that primarily reflect <strong>cholestasis</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0799",
      "difficulty": "medium"
    },
    {
      "text": "In a patient with acute viral hepatitis, what level of serum transaminases will you expect?",
      "choices": [
        {
          "id": 1,
          "text": "10-40 IU/L"
        },
        {
          "id": 2,
          "text": "<500 IU/L"
        },
        {
          "id": 3,
          "text": "40-300 IU/L"
        },
        {
          "id": 4,
          "text": ">1000 IU/L"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>In a patient with <strong>acute viral hepatitis</strong>, serum<strong> transaminases</strong> are elevated to <strong>&gt;1000 IU/L</strong></p>\n<p>The <strong>normal</strong> levels of serum transaminases are <strong>10-40 IU/L</strong>.&nbsp;Marked elevation of serum transaminases&nbsp;&gt;1000 IU/L is seen in conditions with extensive hepatocellular injury. These include:</p>\n<ul>\n<li>Viral hepatitis</li>\n<li>Ischemic injury to the liver in conditions like acute heart failure</li>\n<li>Toxin/drug-induced liver injury</li>\n</ul>\n<p>Minor elevations of serum transaminase levels up to 300 IU/L are non-specific and can be found in any liver disease.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7427",
      "difficulty": "medium"
    },
    {
      "text": "A 64-year-old man with jaundice and abdominal pain was found to have an ALP level of 200 mg/dL. His LFT reports from a month ago had shown an ALP level of 50 mg/dL. What is your inference?",
      "choices": [
        {
          "id": 1,
          "text": "Normal finding for age"
        },
        {
          "id": 2,
          "text": "Could be due to fatty meal intake"
        },
        {
          "id": 3,
          "text": "Indicative of hemolysis"
        },
        {
          "id": 4,
          "text": "Suggestive of cholestatic liver disease"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>A <strong>4 fold rise </strong>of<strong> serum ALP</strong> (alkaline phosphatase)&nbsp;is suggestive of <strong>cholestatic liver disease</strong>. However, serum ALP levels cannot differentiate between extrahepatic and intrahepatic cholestasis.&nbsp;</p>\n<p>The <strong>normal range</strong> for serum ALP is considered <strong>40-125 IU/L</strong>.&nbsp;Serum alkaline phosphatase is found in the liver, bone, small intestines, and placenta. Hence, a <strong>mild increase</strong> in ALP, i.e., 1 - 1.5 times normal, can be seen in these conditions:</p>\n<ul>\n<li>Following a<strong> fatty meal intake&nbsp;</strong>- influx of intestinal alkaline phosphatase into the blood. Hence, the patient is advised to fast before the blood sample is collected for the test.</li>\n<li>In <strong>pregnancy</strong> - placental ALP</li>\n<li>In <strong>children</strong> - rapid bone growth</li>\n<li>In elderly people <strong>over 60 years</strong> of age</li>\n</ul>\n<p>ALP can be raised even in conditions like metastatic bone disease, inflammatory bowel disease, Hodgkin's lymphoma, etc. Hence, it needs to be correlated with raised levels of <strong>gamma-glutamyltransferase</strong> (GGT) and <strong>5' nucleotidase</strong> which are <strong>more specific for liver</strong> disease.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0803",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements regarding liver enzymes is true?",
      "choices": [
        {
          "id": 1,
          "text": "ALT is raised to >1000 IU/L in cirrhosis"
        },
        {
          "id": 2,
          "text": "Absolute levels of aminotransferases correlate with the prognosis"
        },
        {
          "id": 3,
          "text": "AST:ALT ratio <1 is seen in nonalcoholic fatty liver disease"
        },
        {
          "id": 4,
          "text": "AST:ALT ratio >1 is seen in chronic viral hepatitis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>AST:ALT ratio &lt;1</strong> is seen in <strong>NAFLD</strong> (nonalcoholic fatty liver disease).</p>\n<p>The AST:ALT ratio can be interpreted as follows:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>AST:ALT</strong></td>\n<td><strong>Condition</strong></td>\n</tr>\n<tr>\n<td>&lt;1</td>\n<td>Chronic viral hepatitis, Nonalcoholic fatty liver disease</td>\n</tr>\n<tr>\n<td>&gt;1</td>\n<td>Cirrhosis</td>\n</tr>\n<tr>\n<td>&gt;2:1</td>\n<td>\n<p>Suggestive of alcoholic liver disease</p>\n<p>Alcohol intake is associated with the&nbsp;deficiency of pyridoxal phosphate which in turn leads to decreased levels of ALT enzyme. So, AST&gt;ALT.</p>\n</td>\n</tr>\n<tr>\n<td>&gt;3:1</td>\n<td>Highly suggestive of alcoholic liver disease.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Option A: Patients with <strong>cirrhosis</strong> have only <strong>mildly elevated</strong> or even normal levels of serum <strong>transaminases</strong>.</p>\n<p>Option B: <strong>Absolute levels</strong> of <strong>aminotransferases</strong> are not used for predicting prognosis. This is because there is a <strong>poor correlation</strong> between the <strong>degree of liver cell damage</strong> and the levels of aminotransferases.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0798",
      "difficulty": "medium"
    },
    {
      "text": "Liver function tests of a patient show isolated elevation of gamma-glutamyltransferase with other liver enzymes within normal limits. All of the following drugs could be responsible for this finding except:",
      "choices": [
        {
          "id": 1,
          "text": "Barbiturates"
        },
        {
          "id": 2,
          "text": "Griseofulvin"
        },
        {
          "id": 3,
          "text": "Penicillin"
        },
        {
          "id": 4,
          "text": "Phenytoin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Among the given options, penicillin does not lead to elevated gamma-glutamyltransferase&nbsp;(GGT) levels.&nbsp;</p>\n<p><strong>GGT</strong> is a <strong>microsomal enzyme</strong>. Hence, drugs that are microsomal <strong>enzyme</strong> <strong>inducers</strong> can lead to an <strong>increase</strong> in GGT levels. However, other liver enzyme levels will be normal. Therefore, an isolated rise in GGT level does not indicate cholestatic liver disease.</p>\n<p><strong>Drugs that increase levels of GGT</strong> are:</p>\n<ul>\n<li><strong>Barbiturates</strong></li>\n<li>Carbamazepine</li>\n<li>Ethanol</li>\n<li><strong>Griseofulvin</strong></li>\n<li>Rifampicin</li>\n<li><strong>Phenytoin</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7421",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements regarding prothrombin time is false?",
      "choices": [
        {
          "id": 1,
          "text": "Indicates prognosis in acute liver disease"
        },
        {
          "id": 2,
          "text": "Indicates prognosis in chronic liver disease"
        },
        {
          "id": 3,
          "text": "Measures factors II, V, VIII, X"
        },
        {
          "id": 4,
          "text": "Measures factors II, V, VII, X"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Prothrombin time </strong>(PT) can help in estimating the levels of&nbsp;<strong>factors&nbsp;II, V, VII, and X</strong>.</p>\n<p>PT evaluates the <strong>extrinsic</strong> and the <strong>common</strong> <strong>pathway</strong> of coagulation. Factor VII is required in the extrinsic pathway and factors II, V, X are required in the common pathway.</p>\n<p><strong>Coagulation factors</strong> are <strong>produced</strong> <strong>by</strong> the <strong>liver</strong> (except factor VIII) and they have a short half-life. Hence, they <strong>indicate</strong> the <strong>synthetic function</strong> of the liver and are very useful in assessing acute hepatic dysfunction.&nbsp;Factor VIII is produced by vascular endothelial cells.</p>\n<p><strong>Prolonged</strong> <strong>PT</strong> that is not corrected by vitamin K administration indicates <strong>poor prognosis</strong> in both acute and chronic liver disease.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0805",
      "difficulty": "medium"
    },
    {
      "text": "Which among the following is a marker of chronic liver disease?",
      "choices": [
        {
          "id": 1,
          "text": "Prothrombin"
        },
        {
          "id": 2,
          "text": "Albumin"
        },
        {
          "id": 3,
          "text": "5'- nucleosidase"
        },
        {
          "id": 4,
          "text": "Alkaline phosphatase (ALP)"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Serum albumin</strong> is a marker of <strong>chronic liver disease</strong> because it is synthesized by the hepatocytes and has a <strong>long half-life</strong> of 18&ndash;20 days.&nbsp;Serum albumin is not a good indicator of acute or mild hepatic dysfunction.</p>\n<p><strong>Hypoalbuminemia</strong> is more common in chronic liver disorders such as cirrhosis and usually reflects <strong>severe liver damage</strong>.&nbsp;In hepatitis, albumin levels <strong>&lt;3 g/dL</strong> should raise the possibility of chronic liver disease.</p>\n<p><strong>Prothrombin time</strong> is used to assess <strong>acute</strong> parenchymal liver disease. <strong>5' nucleosidase</strong> is elevated in <strong>cholestasis</strong>.&nbsp;Elevation of <strong>ALP</strong> (&lt;3 fold) is <strong>not specific</strong> to liver diseases.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7429",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following can be seen in a patient with chronic liver disease?",
      "choices": [
        {
          "id": 1,
          "text": "Hypergammaglobulinemia"
        },
        {
          "id": 2,
          "text": "Hypogammaglobulinemia"
        },
        {
          "id": 3,
          "text": "Rise in beta globulin levels"
        },
        {
          "id": 4,
          "text": "Rise in alpha globulin levels"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Chronic liver disease</strong> is associated with&nbsp;<strong>hypergammaglobulinemia</strong>.&nbsp;Chronic liver diseases with hypergammaglobulinemia include autoimmune hepatitis, primary biliary cirrhosis, and alcoholic liver disease.</p>\n<p>The liver produces all globulins except gamma globulin<strong>&nbsp;</strong>which&nbsp;are produced by B cells. In <strong>chronic liver diseases</strong> like liver cirrhosis, there is&nbsp;<strong>impaired</strong> <strong>reticuloendothelial</strong> <strong>function</strong> in hepatic sinusoids. Hence the liver fails to clear the&nbsp;bacterial antigens. This causes an increased production of gamma globulin.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0800",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not a marker for liver fibrosis?",
      "choices": [
        {
          "id": 1,
          "text": "Procollagen peptide III (PIIINP)"
        },
        {
          "id": 2,
          "text": "Hyaluronic acid"
        },
        {
          "id": 3,
          "text": "Tissue inhibitor of metalloproteinase 1(TIMP1)"
        },
        {
          "id": 4,
          "text": "Telopeptide"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Telopeptide</strong> is not a marker for liver fibrosis. It is a marker for <strong>bone resorption</strong>.</p>\n<p>Various <strong>non-invasive markers to detect hepatic fibrosis</strong> are given below:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Non-invasive test for fibrosis&nbsp;</strong></td>\n<td><strong>Components tested</strong></td>\n</tr>\n<tr>\n<td>&nbsp;Fibrotest/FibroSure</td>\n<td>\n<ul>\n<li>&alpha;2-macroglobulin</li>\n<li>Haptoglobin</li>\n<li>Apolipoprotein A-1</li>\n<li>GGT</li>\n<li>Total bilirubin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Enhanced Liver Fibrosis (ELF) assay</td>\n<td>\n<ul>\n<li>Hyaluronic acid</li>\n<li><strong>Procollagen peptide III</strong> (PIIINP)</li>\n<li><strong>Tissue inhibitor of metalloproteinase</strong> (TIMP)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Transient elastography (FibroScan)</td>\n<td>\n<ul>\n<li>Ultrasound waves are used to measure liver stiffness</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Fibrospect II</td>\n<td>\n<ul>\n<li><strong>Hyaluronic acid</strong></li>\n<li>Alpha 2 macroglobulin</li>\n<li>Tissue inhibitor of metalloproteinase 1 (TIMP 1)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7424",
      "difficulty": "hard"
    },
    {
      "text": "In which of the following patients planned for a liver biopsy, would you not be required to use the transjugular approach?",
      "choices": [
        {
          "id": 1,
          "text": "A patient with prolonged INR"
        },
        {
          "id": 2,
          "text": "A patient with significant ascites"
        },
        {
          "id": 3,
          "text": "A patient with splenomegaly"
        },
        {
          "id": 4,
          "text": "A morbidly obese patient"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Liver biopsy</strong> can be performed in a patient with <strong>splenomegaly</strong> via the <strong>percutaneous approach</strong>.</p>\n<p>When the percutaneous approach is not advisable, liver biopsy can be performed via the transjugular approach.<strong>&nbsp;</strong>In this approach,<strong>&nbsp;</strong>a cannula is inserted via the jugular vein which is then passed into hepatic veins through which the biopsy sample is taken. Therefore, any bleeding resulting from the procedure will drain into the hepatic veins.</p>\n<p><strong>Indications of transjugular liver biopsy:</strong></p>\n<ul>\n<li>Percutaneous approach contraindicated\n<ul>\n<li>Significant <strong>ascites</strong></li>\n<li><strong>Prolonged INR</strong></li>\n<li>Coagulopathies</li>\n</ul>\n</li>\n<li>Difficulty in accessing the liver via the percutaneous route\n<ul>\n<li>Morbid <strong>obesity</strong></li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7434",
      "difficulty": "hard"
    }
  ]
}